Wells Fargo Downgrades Celgene (CELG) to Market Perform, Cuts PT 'on Serial Disappointment'
Tweet Send to a Friend
Wells Fargo downgraded Celgene (NASDAQ: CELG) from Outperform to Market Perform with a price target of $101.00 (from $163.00).Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
